Drugmakers Rail Against Compulsory Licensing
The Pharmaceutical Research and Manufacturers of America (PhRMA) said that the country didn’t negotiate with the patent holder, Merck & Co. Inc., before issuance.
“The recent announcement by Thailand’s Ministry of Health to issue a compulsory license without any attempt to negotiate with the patent owner is of grave concern,” said Billy Tauzin, president and CEO of PhRMA. “This...
To view the full article, register now.